Acorah Software Products - Accounts Production 16.3.350 false true 31 December 2023 1 January 2023 false 1 January 2024 31 December 2024 31 December 2024 12454084 Mr J E Powell Dr S A Black Dr P Finigan Uk Vein Clinic Group Ltd true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12454084 2023-12-31 12454084 2024-12-31 12454084 2024-01-01 2024-12-31 12454084 frs-core:CurrentFinancialInstruments 2024-12-31 12454084 frs-core:ComputerEquipment 2024-12-31 12454084 frs-core:ComputerEquipment 2024-01-01 2024-12-31 12454084 frs-core:ComputerEquipment 2023-12-31 12454084 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 12454084 frs-core:FurnitureFittings 2024-12-31 12454084 frs-core:FurnitureFittings 2024-01-01 2024-12-31 12454084 frs-core:FurnitureFittings 2023-12-31 12454084 frs-core:OtherResidualIntangibleAssets 2024-12-31 12454084 frs-core:OtherResidualIntangibleAssets 2024-01-01 2024-12-31 12454084 frs-core:OtherResidualIntangibleAssets 2023-12-31 12454084 frs-core:PlantMachinery 2024-12-31 12454084 frs-core:PlantMachinery 2024-01-01 2024-12-31 12454084 frs-core:PlantMachinery 2023-12-31 12454084 frs-core:ShareCapital 2024-12-31 12454084 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 12454084 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12454084 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 12454084 frs-bus:SmallEntities 2024-01-01 2024-12-31 12454084 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 12454084 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12454084 1 2024-01-01 2024-12-31 12454084 frs-bus:Director1 2024-01-01 2024-12-31 12454084 frs-bus:Director2 2024-01-01 2024-12-31 12454084 frs-bus:Director3 2024-01-01 2024-12-31 12454084 frs-countries:EnglandWales 2024-01-01 2024-12-31 12454084 2022-12-31 12454084 2023-12-31 12454084 2023-01-01 2023-12-31 12454084 frs-core:CurrentFinancialInstruments 2023-12-31 12454084 frs-core:ShareCapital 2023-12-31 12454084 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: 12454084
UK Vein Clinic Ltd
Financial Statements
For The Year Ended 31 December 2024
Fairman Harris
1 Landor Road
London
SW9 9RX
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 12454084
2024 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 169,681 19,508
Tangible Assets 5 230,557 180,701
400,238 200,209
CURRENT ASSETS
Stocks 6 121,684 45,167
Debtors 7 2,537,561 1,327,207
Cash at bank and in hand 93,270 145,249
2,752,515 1,517,623
Creditors: Amounts Falling Due Within One Year 8 (3,036,470 ) (1,669,953 )
NET CURRENT ASSETS (LIABILITIES) (283,955 ) (152,330 )
TOTAL ASSETS LESS CURRENT LIABILITIES 116,283 47,879
PROVISIONS FOR LIABILITIES
Deferred Taxation (100,060 ) (46,971 )
NET ASSETS 16,223 908
CAPITAL AND RESERVES
Called up share capital 9 400 400
Profit and Loss Account 15,823 508
SHAREHOLDERS' FUNDS 16,223 908
Page 1
Page 2
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr J E Powell
Director
30 September 2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
UK Vein Clinic Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12454084 . The registered office is Lower Ground Floor, Harley Street, London, W1G 7LQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are set up cost. It is amortised to profit and loss account over its estimated economic life of 3 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 20% Straight Line
Fixtures & Fittings 20% Straight Line
Computer Equipment 20% Straight Line
2.5. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 7)
1 7
4. Intangible Assets
Other
£
Cost
As at 1 January 2024 19,729
Additions 161,507
As at 31 December 2024 181,236
Amortisation
As at 1 January 2024 221
Provided during the period 11,334
As at 31 December 2024 11,555
Net Book Value
As at 31 December 2024 169,681
As at 1 January 2024 19,508
5. Tangible Assets
Plant & Machinery Fixtures & Fittings Computer Equipment Total
£ £ £ £
Cost
As at 1 January 2024 145,334 88,054 23,015 256,403
Additions 113,397 3,840 - 117,237
As at 31 December 2024 258,731 91,894 23,015 373,640
Depreciation
As at 1 January 2024 44,404 27,113 4,185 75,702
Provided during the period 44,848 17,930 4,603 67,381
As at 31 December 2024 89,252 45,043 8,788 143,083
Net Book Value
As at 31 December 2024 169,479 46,851 14,227 230,557
As at 1 January 2024 100,930 60,941 18,830 180,701
6. Stocks
2024 2023
£ £
Materials 121,684 45,167
Page 4
Page 5
7. Debtors
2024 2023
£ £
Due within one year
Trade debtors 41,034 92,575
Prepayments and accrued income 111,583 64,296
Other debtors 10 5,701
Directors' loan accounts - 10
Amounts owed by group undertakings 2,281,717 1,046,245
Amounts owed by associates 103,217 118,380
2,537,561 1,327,207
8. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 313,293 240,669
Corporation tax - 11,882
Other creditors 10,195 35,205
Accruals and deferred income 47,925 88,370
Amounts owed to associates 2,665,057 1,293,827
3,036,470 1,669,953
9. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 400 400
10. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors: £226,769.
The above loan is unsecured, interest free and repayable on demand.
11. Related Party Transactions
Uk Vein Clinic Group Limited - Intercompany balance:  Dr £2,281,717 (2023 Dr £1,046,245)
Dr Newmans Clinics Limited - Intercompany balance: Cr £2,180,571 (2023 Cr 996,725)
Uk Vein Clinic (Thames Valley) Limited - Intercompany balance: Cr £392,608 (2023 Cr £297,102)
Uk Vein Clinic ( Surrey) Limited - Intercompany balance: Dr £103,217 ( 2023 Dr £47,621)
Uk Vein Clinic Cambridge Limited -Intercompany balance : Cr £91,878 ( 2023 Dr £8,019)
12. Ultimate Controlling Party
The company's ultimate controlling party is Uk Vein Clinic Group Ltd by virtue of its ownership of 75% or more of the issued share capital in the company.
Page 5